Drugmakers shun FDA pilot program on drug names

10/13/2011 | Pharmalot.com

The FDA asked drugmakers to participate in a pilot program designed to reduce errors caused by similarly named drugs. Three drugmakers registered for the program during the past two years, and only one submitted a complete application.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
Nationwide, SL_Nationwide
Finance Manager - ENT
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA